ADVFN UK Market News

Category: Market News

  • Greggs Sets Date for Q4 Trading Update in January

    Greggs Sets Date for Q4 Trading Update in January

    Greggs plc (LSE:GRG) has confirmed that it will publish its fourth-quarter trading update on 8 January 2026, providing the market with an update on performance toward the end of the financial year.

    The announcement is expected to offer insight into trading conditions and operational progress within the highly competitive food-on-the-go sector. Investors will be watching closely for commentary on sales trends, cost pressures, and the company’s outlook as it enters the new year.

    From a market perspective, Greggs continues to benefit from strong underlying financial performance and a track record of positive corporate developments. Technical indicators remain supportive, and valuation levels are viewed as reasonable, offering a balanced mix of growth potential and income appeal.

    More about Greggs plc

    Greggs plc is a leading UK food-on-the-go retailer, best known for its range of freshly prepared baked goods, sandwiches, and drinks. The company operates an extensive store network and serves customers seeking convenient, value-driven meal options across the UK.

  • Arrow Exploration Delivers Ahead-of-Expectations Output From Mateguafa HZ7 Well

    Arrow Exploration Delivers Ahead-of-Expectations Output From Mateguafa HZ7 Well

    Arrow Exploration Corp. (LSE:AXL) has reported strong initial production results from the newly drilled Mateguafa HZ7 well in Colombia’s Llanos Basin, with the well brought on stream on schedule and within budget.

    Early production from HZ7 averaged 1,694 barrels of oil per day on a gross basis, exceeding management expectations. The oil produced is light, with an API gravity of 30.6°, and has shown a very low water cut, supporting the quality and commercial potential of the reservoir. These results further validate the Mateguafa Attic area as an emerging core asset within Arrow’s portfolio.

    Building on this success, the company plans to drill additional horizontal and vertical wells in the area as part of its ongoing development programme. Management said the performance at HZ7 underlines Arrow’s broader growth strategy and strengthens its positioning as it continues to scale production across its Colombian assets.

    More about Arrow Exploration Corp

    Arrow Exploration Corp. is an oil and gas production company operating in Colombia through its wholly owned subsidiary, Carrao Energy S.A. The group holds interests across several prolific basins, including Llanos, Middle Magdalena Valley, and Putumayo, and focuses on expanding production while benefiting from Brent-linked light oil pricing, low royalty rates, and high working interests to deliver attractive operating margins.

  • Bluebird Mining Ventures Unveils Fundraising and Capital Restructuring Plans to Support Gold Strategy

    Bluebird Mining Ventures Unveils Fundraising and Capital Restructuring Plans to Support Gold Strategy

    Bluebird Mining Ventures (LSE:BMV) has outlined plans for a £627,450 equity raise alongside a series of capital reorganisation initiatives aimed at reinforcing its financial position and advancing its gold-focused streaming and treasury strategy.

    The proposed measures include the acquisition of legacy loan positions, the introduction of structured equity subscription arrangements, the cancellation of outstanding warrants, and broader balance sheet stabilisation efforts. Together, these actions are intended to simplify the company’s capital structure, enhance financial discipline, and provide a more robust platform for executing its long-term growth strategy.

    Management said the restructuring is designed to support the development of a scalable operating model within a regulated framework, positioning the company to take advantage of opportunities in the gold-streaming sector while improving operational resilience.

    More about Bluebird Merchant Ventures

    Bluebird Mining Ventures operates in the gold streaming and treasury space, offering investors exposure to physical gold without direct mining risk. The company focuses on securing streams from producing assets across the ore concentrate to bullion value chain, with an emphasis on disciplined capital allocation, treasury management, and the delivery of sustainable, long-term shareholder value.

  • Blencowe Highlights Expanded Graphite Resource Potential at Iyan Deposit

    Blencowe Highlights Expanded Graphite Resource Potential at Iyan Deposit

    Blencowe Resources Plc (LSE:BRES) has reported encouraging new drilling results from the Iyan deposit, located adjacent to the Northern Syncline area within its Orom-Cross graphite project in Uganda. Recent deep drilling has identified thick, continuous graphite mineralisation, including high-grade zones that point to production potential extending well beyond the 15-year mine life outlined in the project’s definitive feasibility study.

    The company said the latest results support the case for multi-decade graphite production, significantly enhancing the overall scale of the Orom-Cross project. In addition, assay results from 186 shallow and step-out drill holes are still pending, with an upgraded JORC-compliant resource estimate expected in early 2026. This update could further strengthen the project’s strategic importance in global graphite supply chains.

    Despite the positive exploration progress, Blencowe continues to face financial and operational challenges. The company currently has no revenue and remains loss-making, with negative cash flows weighing on overall sentiment. While recent funding activity and strategic partnerships offer some support for longer-term development, near-term financial constraints and bearish technical indicators continue to dominate the outlook.

    More about Blencowe Resources Plc

    Blencowe Resources Plc is a mining exploration and development company focused on graphite. Its flagship asset is the Orom-Cross graphite project in northern Uganda, which is being advanced as a potential long-life source of graphite for international markets seeking secure and strategic supply.

  • SkinBioTherapeutics Starts FY Positively and Maintains 2026 Growth Guidance

    SkinBioTherapeutics Starts FY Positively and Maintains 2026 Growth Guidance

    SkinBioTherapeutics plc (LSE:SBTX) said trading has started well in the current financial year, prompting the company to reaffirm its full-year expectations for 2026. Management confirmed that revenue remains forecast at £6.2 million, with adjusted EBITDA projected at £0.7 million, in line with previous guidance.

    The outlook reflects continued progress in strengthening the company’s position within the skincare and gut–skin health markets. Growth is being supported by an expanding product portfolio, commercial partnerships, and strategic initiatives aimed at widening distribution and enhancing brand visibility across key channels.

    Despite the positive operational update, SkinBioTherapeutics continues to face financial pressures, including ongoing losses and cash outflows. Market indicators remain cautious, with technical trends signalling weakness. While recent corporate actions and strategic developments could provide longer-term benefits, improved financial performance will be required before sentiment meaningfully shifts.

    More about SkinBioTherapeutics

    SkinBioTherapeutics is a UK-based life sciences company specialising in skin health technologies. The business is built around its proprietary SkinBiotix® platform, developed at the University of Manchester, and operates across cosmetic skincare and food supplements targeting the gut–skin axis. Its AxisBiotix™ products are distributed through partnerships, retail outlets such as Superdrug, and online platforms including Amazon, alongside a strategy of selective acquisitions to expand reach and capabilities.

  • CyanConnode Delivers Robust H1 FY2026 Growth as Smart Metering Demand Accelerates

    CyanConnode Delivers Robust H1 FY2026 Growth as Smart Metering Demand Accelerates

    CyanConnode (LSE:CYAN) reported a strong first-half performance for FY2026, reflecting continued momentum in India’s expanding smart metering market. During the period, the company secured a major £70 million AMISP contract in Goa, a win that almost doubled its order pipeline to £157 million and underlines its growing role in India’s national smart metering rollout.

    Revenue for the half year increased 32% year on year to £7.4 million, supported largely by higher hardware shipments. Profitability, however, remained under pressure due to lower margins and rising operating costs. Management said these challenges are being addressed through the introduction of new, lower-cost product offerings aimed at improving margins as volumes scale.

    Despite ongoing operational losses, the company’s medium-term outlook remains constructive. CyanConnode expects sustained growth through FY2027, driven by contract execution in India and further expansion into international markets, including the Middle East and North Africa. While recent corporate progress and supportive technical indicators point to potential upside, financial risks remain, particularly around profitability and leverage.

    More about CyanConnode Holdings

    CyanConnode is a global provider of IoT communications and smart metering solutions focused on energy and infrastructure applications. Its technology portfolio includes narrowband RF mesh, advanced cellular modules, and hybrid communication platforms designed for scalable, cost-effective connectivity. The company’s Omnimesh platform delivers self-forming, self-healing networks, while its Universal Head-End System enables interoperability across multiple technologies. CyanConnode works with utilities and system integrators across regions including India, Southeast Asia, the Middle East, and Europe, supporting the digital transformation of energy networks.

  • Avacta Reports Encouraging Preclinical Results for Tumour-Activated Cancer Therapy

    Avacta Reports Encouraging Preclinical Results for Tumour-Activated Cancer Therapy

    Avacta Group plc (LSE:AVCT) has published new preclinical pharmacology data for its tumour-targeted drug candidate FAP-Exd (AVA6103), highlighting its potential to deliver highly potent cancer therapy directly within tumour tissue. The candidate is designed to release a topoisomerase I inhibitor selectively in the tumour microenvironment, with the aim of improving efficacy while limiting systemic exposure.

    The data demonstrated increased tumour-specific cell killing, sustained intratumoural drug release lasting up to five days, and durable anti-tumour responses across preclinical models. Avacta also noted that artificial intelligence has been applied to clinical trial design, helping to optimise patient selection and streamline development. The programme is now being prepared for a Phase 1 clinical trial, targeted to begin in early 2026.

    Despite the positive scientific and development milestones, the group continues to face notable financial and valuation pressures. Ongoing losses and dependence on external funding remain key challenges, even as recent technical signals and corporate progress offer some support to the longer-term investment case.

    More about Avacta Group plc

    Avacta Group plc is a clinical-stage biopharmaceutical company developing novel oncology treatments based on its proprietary pre|CISION® platform. The technology uses tumour-specific protease activation to deliver highly potent drug payloads directly to cancer cells, with the goal of improving therapeutic outcomes while reducing damage to healthy tissue.

  • ECR Minerals Strengthens Production Strategy with Raglan Gold Project Purchase

    ECR Minerals Strengthens Production Strategy with Raglan Gold Project Purchase

    ECR Minerals PLC (LSE:ECR) has completed a binding agreement to acquire the Raglan Project, a fully permitted alluvial gold operation located in Queensland, Australia. The transaction, valued at A$1.01 million, will be funded from the company’s existing cash resources.

    The acquisition is expected to provide near-term production potential, with mining equipment and supporting infrastructure already in place. Management said Raglan will complement the group’s Blue Mountain operations and support its strategy of accelerating revenue generation while transitioning toward a more production-focused business model.

    Beyond immediate operational benefits, the Raglan Project also offers exploration upside and potential tax efficiencies arising from unutilised losses associated with the asset. Together, these factors are expected to contribute to longer-term growth and enhance ECR’s operational footprint in Australia’s gold sector.

    More about ECR Minerals

    ECR Minerals PLC is an Australia-focused gold exploration and development company. Through its subsidiaries, including ECR Minerals (Australia) Pty Ltd and ECR Minerals (Queensland) Pty Ltd, the group manages a portfolio of projects such as Bailieston, Creswick, Tambo, Blue Mountain, and Lolworth Range, with a strategic emphasis on advancing both production and exploration activities.

  • Tiger Alpha Prepares KDN-1 Launch to Drive Scalable AI Infrastructure Growth

    Tiger Alpha Prepares KDN-1 Launch to Drive Scalable AI Infrastructure Growth

    Tiger Alpha PLC (LSE:TIR) has provided an update on its wholly owned artificial intelligence infrastructure project, formerly referred to as the Tiger Alpha subnet and now rebranded as the Knowledge Delivery Network (KDN-1). The platform is scheduled for launch in the first quarter of 2026 and is intended to support more efficient, scalable AI operations.

    KDN-1 is designed to lower operating costs and reduce latency by caching AI knowledge in a similar way to how content delivery networks distribute digital content. Management believes this approach could significantly improve performance for decentralised AI applications and position the company to benefit from accelerating demand across the decentralised AI ecosystem.

    The project is expected to enhance Tiger Alpha’s strategic exposure to emerging AI infrastructure markets, with the potential to attract enterprise users seeking more efficient deployment models. If successful, KDN-1 could strengthen the group’s foothold in frontier technology sectors and support long-term growth opportunities for shareholders.

    More about Tiger Alpha PLC

    Tiger Alpha PLC is an AIM-listed investment company focused on developing and incubating high-growth opportunities across technology and mining. The group targets frontier areas including artificial intelligence, decentralised infrastructure, and digital asset networks, while continuing to pursue investments in natural resources alongside its technology strategy.

  • Eden Research Secures Syngenta Partnership for Evelta Fungicide Rollout

    Eden Research Secures Syngenta Partnership for Evelta Fungicide Rollout

    Eden Research plc (LSE:EDEN) has entered into an exclusive distribution agreement with Syngenta Crop Protection AG for its fungicide product Evelta™, covering the professional ornamental crop market across several European Union countries and the UK. The deal represents Eden’s first commercial partnership with a major global crop protection group and marks a significant step in broadening the company’s commercial footprint.

    Under the agreement, Syngenta will manage the distribution of Evelta™, supporting Eden’s strategy to accelerate market penetration while maintaining a focus on sustainable crop protection solutions. Management said the partnership is expected to strengthen execution capabilities, extend reach to professional growers, and enhance long-term value creation for stakeholders.

    From a market perspective, Eden continues to face financial headwinds alongside cautious technical signals. However, recent corporate developments, including regulatory approvals for its products and instances of insider share purchases, are viewed as constructive indicators that could support future growth and improved investor sentiment.

    More about Eden Research

    Eden Research plc develops sustainable biopesticide and biocontrol technologies for the global agricultural sector. The company focuses on environmentally responsible fungicides and works with international partners to expand market access, helping growers adopt more sustainable and effective crop protection practices.